C-PSJKBlue Rock Therapeutics (owned by Bayer)
cell therapy, cellular medicine
replacementreplacingcell therapy
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-PSJK
C-PSJKC-PSJKcell therapy, cellular medicine
0-100 chain-logic scale · 15 dimensions · scored on public evidence
BlueRock Therapeutics states that it is an engineered cell therapy company focused on developing regenerative medicines for intractable diseases. It expresses a belief that native cell therapies, produced by recapitulating developmental biology and further engineered for added function, can replace damaged or degenerated tissue and thereby restore or regenerate lost function. The company also states that its culture is defined by scientific innovation, the highest ethical standards, and urgency in bringing regenerative medicines to everyone who could benefit.
SourceBlueRock Therapeutics states that healthy cells are the only true solution for degenerative disease and that cell therapies can restore the body’s native functions in ways conventional medicines cannot. The company presents itself as pursuing transformative, ethically grounded, science-driven treatments that replace dead, damaged, or dysfunctional cells to alter disease course and improve patients’ quality of life.
SourceIn the visible text of this snapshot, BlueRock Therapeutics presents itself as a stem cell therapy company; the only clear stated belief is that stem cell therapy is the core approach the company is being launched to pursue.
Source